Table 2.

Sarcopenia, mGFR and nutritional status of strength group, balance group and whole group

	Balance group						Strength group				Whole group
Characteristics	n	Baseline	12 months	P-value	95% CI	n	Baseline	12 months	P-value	95% CI	n	Baseline	12 months	P-value	95% CI
mGFR (mL/min/1.73 m2), mean ± SD	55	22.3 ± 6.9	21.1 ± 7.8	0.003	0.7–3.2	49	23.0 ± 9.1	22.0 ± 9.7	0.01	0.5–3.7	104	22.6 ± 8.0	21.6 ± 8.8	<0.001	1.0–3.0
Sarcopenia, n (%)	56	7 (7)	8 (8)	1	0.34–4.10	47	3 (3)	3 (3)	1	0.13–7.88	103	10 (11%)	11 (11)	1	0.41–3.06
Nutritional status
SGA (A/B/C), n	59	55A/4B/0C	55A/4B/0C	–	–	53	47A/6B/0C	46A/6B/1C	–	–	112	102A/10B/0C	101A/10B/1C	–	–
nPCR (g/kg body weight/day), median (25th–75th percentiles)	45	0.9 (0.7–1.1)	0.9 (0.7–1.5)	0.4	−0.83–0.05	42	0.9 (0.8–1.0)	0.9 (0.7–1.1)	0.3	−0.29–0.06	87	0.9 (0.7–1.1)	0.9 (0.7–1.3)	0.1	−0.28–0.02
BMI (kg/m2), mean ±  SD	59	27.0 ± 4.7	26.6 ± 4.1	0.1	−0.05–0.75	53	28.0 ± 5.2	27.7 ± 5.0	0.1	−0.10–0.70	112	27.4 ± 4.9	27.1 ± 4.6	0.03	0.05–0.60

CI, confidence interval. A P-value < 0.05 was considered statistically significant.